1. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37 (5): 1236-41.
2. Федорович А.А. Функциональное состояние регуляторных механизмов микроциркуляторного кровотока в норме и при артериальной гипертензии по данным лазерной допплеровской флоуметрии. Регионарное кровообращение и микроциркуляция. 2010; 9 (1): 33-45.
3. Маколкин В.И., Подзолков В.И., Бранько В.В. Микроциркуляция в кардиологии. М.: Визарт, 2004.
4. Федорович А.А., Гориева Ш.Б., Рогоза А.Н. и др. Функциональное состояние регуляторных механизмов микроциркуляторного кровотока в норме и при артериальной гипертензии по данным лазерной допплеровской флоуметрии. Мед. алфавит. 2014; 2 (14): 58-68.
5. Беленков Ю.Н., Привалова Е.В., Данилогорская Ю.А. и др. Ремоделирование сосудистого русла у больных артериальной гипертонией: возможности диагностики и коррекции. Кардиология. 2012; 6: 67-72.
6. Ершова А.И. Биохимические показатели и структурно - функциональные особенности каротидных артерий и аорты у больных семейной гиперхолестеринемией. Дис. … канд. мед. наук. М., 2012.
7. Laurent S, Cockcroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27 (21): 2588-605.
8. Nürnberger J, Keflioglu-Scheiber A, Opazo Saez A.M et al. Augmentation index is associated with cardiovascular risk. J. Hypertens 2002; 20 (12): 2407-14.
9. Vlachopoulos C, Aznaouridis K, O’Rourke M.F et al. Prediction of cardiovascular events and all - cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31 (15): 1865-71.
10. Rosenwasser R.F, Shah N.K, Smith S.M et al. Baseline predictors of central aortic blood pressure: a PEAR substudy. J Am Soc Hypertens 2014; 8 (3): 152-8.
11. Izzo J.L. Brachial vs. central systolic pressure and pulse wave transmission indicators: a critical analysis. Am J Hypertens 2014; 27 (12): 1433-42.
12. Крупаткин А.И. Клиническая нейроангиофизиология конечностей. М.: Научный мир, 2003.
13. Крупаткин А.И., Сидоров В.В. Лазерная допплеровская флоуметрия микроциркуляции крови. М.: Медицина, 2005.
14. Rossi M, Bradbury A, Magagna A et al. Investigation of skin vasoreactivity and blood flow oscillations in hypertensive patients: effect of short-term antihypertensive treatment. J Hypertens 2011; 29 (8): 1569-76.
15. Dart A, Silagy C, Dewar E et al. Aortic distensibility and left ventricular structure and function in isolated systolic hypertension. Eur Heart J 1993; 14 (11): 1465-70.
16. Puato M, Palatini P, Zanardo M et al. Increase in carotid intima - media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 2008; 51 (5): 1300-5.
17. Urbina E.M, Khoury P.R, Mc Coy C.E et al. Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics 2013; 131 (4): 1082-90.
18. Bellido C.A, Iavicoli O.R, Rusak E.J et al. Continuous improvement of arterial compliance beyond blood pressure decrease after 5 years of antihypertensive treatment. J Clin Hypertens (Greenwich) 2006; 8: 555-60.
19. Kosch M, Levers A, Lang D et al. A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension. Nephrol Dial Transplant 2008; 23: 2280-5.
20. Song H, Bao W, Wang H et al. Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension. Clin Chem Lab Med 2008; 46: 393-5.
21. Schiffrin E.L, Deng L.Y. Comparison of effects of angiotensin Iconverting enzyme inhibition and beta - blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995; 25: 699-703.
22. Schiffrin E.L, Deng L.Y, Larochelle P. Effects of a beta - blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83-91.
23. Schiffrin E.L, Deng L.Y, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker. Am J Hypertens 1995; 8: 229-36.
24. Ghiadoni L, Virdis A, Magagna A et al. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension 2000; 35: 501-6.
25. Schiffrin E.L, Park J.B, Pu Q. Effect of crossing over hypertensive patients from a beta - blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens 2002; 20: 71-8.
26. Rizzoni D, Porteri E, De Ciuceis C et al. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin - dependent diabetes mellitus. Hypertension 2005; 45: 659-65.
27. Savoia C, Touyz R.M, Endemann D.H et al. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension 2006; 48: 271-7.